|
AKAP13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6974199823494E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62503344114384E-12 |
| Normal-vs-Stage2 |
1.342330E-03 |
| Normal-vs-Stage3 |
9.96469999999805E-05 |
| Normal-vs-Stage4 |
2.798300E-03 |
| Stage1-vs-Stage2 |
1.060220E-01 |
| Stage1-vs-Stage3 |
3.622900E-04 |
| Stage1-vs-Stage4 |
1.021250E-03 |
| Stage2-vs-Stage3 |
4.472200E-01 |
| Stage2-vs-Stage4 |
3.862000E-01 |
| Stage3-vs-Stage4 |
7.995000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.30069305221059E-13 |
| Normal-vs-AfricanAmerican |
1.057940E-03 |
| Normal-vs-Asian |
5.543700E-02 |
| Caucasian-vs-AfricanAmerican |
8.727200E-01 |
| Caucasian-vs-Asian |
2.815600E-01 |
| AfricanAmerican-vs-Asian |
4.354000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.73863179198497E-12 |
| Normal-vs-Female |
6.47489950544866E-10 |
| Male-vs-Female |
7.439600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.360700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.16870965630278E-12 |
| Normal-vs-Age(61-80Yrs) |
9.9546000331685E-09 |
| Normal-vs-Age(81-100Yrs) |
1.513380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.657800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.177580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.096500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.284100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.579900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.368000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.607500E-04 |
| Normal-vs-Grade 2 |
1.63746793901964E-12 |
| Normal-vs-Grade 3 |
4.47809999970517E-07 |
| Normal-vs-Grade 4 |
4.056800E-03 |
| Grade 1-vs-Grade 2 |
5.947800E-02 |
| Grade 1-vs-Grade 3 |
5.636500E-04 |
| Grade 1-vs-Grade 4 |
9.985000E-04 |
| Grade 2-vs-Grade 3 |
1.262260E-03 |
| Grade 2-vs-Grade 4 |
7.404300E-03 |
| Grade 3-vs-Grade 4 |
5.857600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.00710584105946E-14 |
| Normal-vs-ccB subtype |
5.77700000059522E-08 |
| ccA subtype-vs-ccB subtype |
8.488300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.36780031745332E-10 |
| Normal-vs-N1 |
7.861900E-02 |
| N0-vs-N1 |
8.385400E-01 |
|
|
